This company has been marked as potentially delisted and may not be actively trading. Soaring Eagle Acquisition (SRNG) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock SRNG vs. PRME, IKT, PLX, IZTC, CVM, ZIVO, CRTX, JATT, FNCH, and ALVRShould you be buying Soaring Eagle Acquisition stock or one of its competitors? The main competitors of Soaring Eagle Acquisition include Prime Medicine (PRME), Inhibikase Therapeutics (IKT), Protalix BioTherapeutics (PLX), Invizyne Technologies (IZTC), CEL-SCI (CVM), ZIVO Bioscience (ZIVO), Cortexyme (CRTX), JATT Acquisition (JATT), Finch Therapeutics Group (FNCH), and AlloVir (ALVR). Soaring Eagle Acquisition vs. Its Competitors Prime Medicine Inhibikase Therapeutics Protalix BioTherapeutics Invizyne Technologies CEL-SCI ZIVO Bioscience Cortexyme JATT Acquisition Finch Therapeutics Group AlloVir Soaring Eagle Acquisition (NASDAQ:SRNG) and Prime Medicine (NYSE:PRME) are both biological products, except diagnostic industry companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, media sentiment, earnings and dividends. Does the media prefer SRNG or PRME? In the previous week, Prime Medicine had 5 more articles in the media than Soaring Eagle Acquisition. MarketBeat recorded 5 mentions for Prime Medicine and 0 mentions for Soaring Eagle Acquisition. Soaring Eagle Acquisition's average media sentiment score of 0.20 beat Prime Medicine's score of 0.09 indicating that Soaring Eagle Acquisition is being referred to more favorably in the media. Company Overall Sentiment Soaring Eagle Acquisition Neutral Prime Medicine Neutral Which has higher valuation & earnings, SRNG or PRME? Soaring Eagle Acquisition has higher earnings, but lower revenue than Prime Medicine. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSoaring Eagle AcquisitionN/AN/AN/AN/AN/APrime Medicine$4.96M102.94-$198.13M-$1.56-2.43 Is SRNG or PRME more profitable? Soaring Eagle Acquisition's return on equity of 0.00% beat Prime Medicine's return on equity.Company Net Margins Return on Equity Return on Assets Soaring Eagle AcquisitionN/A N/A N/A Prime Medicine N/A -107.87%-74.97% Do institutionals & insiders hold more shares of SRNG or PRME? 41.2% of Soaring Eagle Acquisition shares are owned by institutional investors. Comparatively, 70.4% of Prime Medicine shares are owned by institutional investors. 22.7% of Prime Medicine shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Do analysts rate SRNG or PRME? Prime Medicine has a consensus price target of $8.92, suggesting a potential upside of 134.96%. Given Prime Medicine's stronger consensus rating and higher possible upside, analysts clearly believe Prime Medicine is more favorable than Soaring Eagle Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Soaring Eagle Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Prime Medicine 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.75 SummaryPrime Medicine beats Soaring Eagle Acquisition on 8 of the 11 factors compared between the two stocks. Get Soaring Eagle Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for SRNG and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SRNG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRNG vs. The Competition Export to ExcelMetricSoaring Eagle AcquisitionBiological Products, Except Diagnostic IndustryEnergy SectorNASDAQ ExchangeMarket Cap$2.41B$285.30M$7.69B$9.96BDividend YieldN/AN/A10.80%4.53%P/E RatioN/AN/A39.6026.32Price / SalesN/A474.99578.7287.41Price / CashN/A22.4435.3929.14Price / BookN/A10.853.976.14Net IncomeN/A-$115.81M$4.28B$269.83M Soaring Eagle Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRNGSoaring Eagle AcquisitionN/A$11.19+0.4%N/A+97.3%$2.41BN/A0.00N/APRMEPrime Medicine3.4163 of 5 stars$3.24-5.8%$8.92+175.2%+9.6%$436.02M$4.96M-1.58234News CoverageGap UpIKTInhibikase Therapeutics1.6055 of 5 stars$1.80-2.2%$6.50+261.1%+23.9%$134.13MN/A-0.676Positive NewsPLXProtalix BioTherapeutics3.1374 of 5 stars$1.55flat$15.00+867.7%+58.0%$123.59M$61.95M-11.92200Positive NewsIZTCInvizyne TechnologiesN/A$9.70flatN/AN/A$103.16MN/A0.0029Gap UpCVMCEL-SCI0.7141 of 5 stars$10.43+12.0%N/A-67.8%$71.78MN/A-21.7343News CoverageShort Interest ↑ZIVOZIVO Bioscience0.0624 of 5 stars$17.01flatN/A+35.0%$64.93M$15.85K-3.4910News CoverageCRTXCortexymeN/A$1.60+3.9%N/A+130.7%$48.24MN/A-0.5455JATTJATT AcquisitionN/A$2.04-3.8%N/A-39.2%$35.19MN/A0.003High Trading VolumeFNCHFinch Therapeutics Group0.5 of 5 stars$13.00flatN/AN/A$20.88MN/A-1.47190ALVRAlloVirN/A$4.08+14.6%N/A-73.7%$20.58MN/A-0.20110Gap DownHigh Trading Volume Related Companies and Tools Related Companies PRME Alternatives IKT Alternatives PLX Alternatives IZTC Alternatives CVM Alternatives ZIVO Alternatives CRTX Alternatives JATT Alternatives FNCH Alternatives ALVR Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SRNG) was last updated on 9/9/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Soaring Eagle Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Soaring Eagle Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
